Regeneron Pharmaceuticals is set to acquire 23andMe for $256 million following its bankruptcy filing due to declining demand ...

Regeneron Pharmaceuticals said it will acquire 23andMe's business. What happened to 23andMe? Should you delete your data?

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...

Regeneron acquires bankrupt 23andMe for $256M. What this DNA data sale means for privacy, pharma, and your genetic ...

Genetic testing company 23andMe is being acquired, shortly after it declared bankruptcy months ago.

South San Francisco, California-based 23andMe filed for bankruptcy last month, seeking to sell its business at auction after ...

The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...

In its announcement of the acquisition, Regeron claimed it would ensure that customers’ personal data including genetic and ...

To acquire 23andMe’s Personal Genome Service, Total Health and Research Services business lines, and its Biobank and ...